Imperial College commences mRNA cancer therapy trial in UK—it made me sick to my stomach...
...Moderna and UK Government experiementing with peoples lives.
Imperial College Healthcare NHS Trust has commenced dosing patients
Subscribers may remember my posting how MHRA had been the only regulatory authority in the world to allow mRNA therapies to be cooked up in hospitals, with no skills in manufacture. This is the post, and below you can see they are doing it—sponsored by Moderna!
Imperial College commences mRNA cancer therapy trial in UK
When I read it, I could have thrown up. This is how the article begins:
Imperial College Healthcare NHS Trust has commenced dosing of the first subjects in the UK with experimental messenger ribonucleic acid (mRNA) therapy, mRNA-4359, in a Phase I/II clinical trial to treat solid tumours, including melanoma and lung cancer. This immunotherapy is designed to trigger the immune system of the patient by presenting common tumour markers.
An 81-year-old man from Surrey, diagnosed with treatment-resistant malignant melanoma, was the first UK recipient of mRNA-4359.
It is sponsored by Moderna, which plans to enrol subjects across the globe over the coming three years.
The primary goal is to assess the safety and tolerability of mRNA-4359, either as a monotherapy or along with pembrolizumab, an immune checkpoint inhibitor.
MHRA claims point of care manufacture is safe, when it’s not
Last July, I received a letter from MHRAs Laura Squire, following my submission of a question to an MHRA Board Meeting. This is it below:
It says “The detail of the Point of Care (PoC) is being developed.”
As we all know, the devil is in the detail, and this is patient lives we are talking about.
The article tells us: An 81-year-old man from Surrey, diagnosed with treatment-resistant malignant melanoma, was the first UK recipient of mRNA-4359.
The detail is substantial, as you may have guessed. Where are the raw materials coming from? Have the suppliers been audited? Who will test to confirm suitable quality? Are the people manufacturing the clinical trial supplies qualified and trained properly? Who is repsonsible for writing the standard operating procedures (SOP)?
There’s a long list of other questions to be answered.
This is a thin end of a very large wedge.
The "experimental messenger RNA" is really "MODIFIED RNA". We know that has worked well and is safe............. oh no there is no evidence to show that!
Why would you tamper with an immune system? The "incredibly irreducibly complex" immune system that is not sufficiently understood, implying that they can augment this system by injecting people is audacious, crazy and extraordinary.
The MHRA reply does not state how the GMP will be guaranteed or what records will prove that it has. Authorities normally require proof that it has and that the requisite standards are being met.